Healthy Living/WellnessFDA approves AstraZeneca's EPANOVA, adjunct to diet for people with very high triglyceride levels AstraZeneca won the approval of the FDA for Epanova, a new pill for heart diseases. Epanova is a fish oil-based medication that will compete against GlaxoSmithKline’s Lovaza and Amarin’s Vascepa.by Anne Francis
